These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30810135)

  • 21. Biodegradable, Hydrogen Peroxide, and Glutathione Dual Responsive Nanoparticles for Potential Programmable Paclitaxel Release.
    Chen D; Zhang G; Li R; Guan M; Wang X; Zou T; Zhang Y; Wang C; Shu C; Hong H; Wan LJ
    J Am Chem Soc; 2018 Jun; 140(24):7373-7376. PubMed ID: 29799737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface charge-switchable polymeric magnetic nanoparticles for the controlled release of anticancer drug.
    Shen JM; Yin T; Tian XZ; Gao FY; Xu S
    ACS Appl Mater Interfaces; 2013 Aug; 5(15):7014-24. PubMed ID: 23815399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy.
    Ma X; Özliseli E; Zhang Y; Pan G; Wang D; Zhang H
    Biomater Sci; 2019 Jan; 7(2):634-644. PubMed ID: 30534690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma.
    Li X; Qin F; Yang L; Mo L; Li L; Hou L
    Int J Nanomedicine; 2014; 9():3971-85. PubMed ID: 25170267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
    Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering folate-targeting diselenide-containing triblock copolymer as a redox-responsive shell-sheddable micelle for antitumor therapy in vivo.
    Behroozi F; Abdkhodaie MJ; Abandansari HS; Satarian L; Molazem M; Al-Jamal KT; Baharvand H
    Acta Biomater; 2018 Aug; 76():239-256. PubMed ID: 29928995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of polymer-paclitaxel conjugate linked via a disulfide bond.
    Yan Q; Yang Y; Chen W; Hu J; Yang D
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():580-5. PubMed ID: 26478347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted antitumor comparison study between dopamine self-polymerization and traditional synthesis for nanoparticle surface modification in drug delivery.
    Zhang M; Zou Y; Zuo C; Ao H; Guo Y; Wang X; Han M
    Nanotechnology; 2021 May; 32(30):. PubMed ID: 33862617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH-responsive high-density lipoprotein-like nanoparticles to release paclitaxel at acidic pH in cancer chemotherapy.
    Shin JY; Yang Y; Heo P; Lee JC; Kong B; Cho JY; Yoon K; Shin CS; Seo JH; Kim SG; Kweon DH
    Int J Nanomedicine; 2012; 7():2805-16. PubMed ID: 22745543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving paclitaxel delivery: in vitro and in vivo characterization of PEGylated polyphosphoester-based nanocarriers.
    Zhang F; Zhang S; Pollack SF; Li R; Gonzalez AM; Fan J; Zou J; Leininger SE; Pavía-Sanders A; Johnson R; Nelson LD; Raymond JE; Elsabahy M; Hughes DM; Lenox MW; Gustafson TP; Wooley KL
    J Am Chem Soc; 2015 Feb; 137(5):2056-66. PubMed ID: 25629952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction/Oxidation-Responsive Hierarchical Nanoparticles with Self-Driven Degradability for Enhanced Tumor Penetration and Precise Chemotherapy.
    Yin S; Gao Y; Zhang Y; Xu J; Zhu J; Zhou F; Gu X; Wang G; Li J
    ACS Appl Mater Interfaces; 2020 Apr; 12(16):18273-18291. PubMed ID: 32223148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanomedicine-based paclitaxel induced apoptotic signaling pathways in A562 leukemia cancer cells.
    Wang Y; Zhou L; Xiao M; Sun ZL; Zhang CY
    Colloids Surf B Biointerfaces; 2017 Jan; 149():16-22. PubMed ID: 27716527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
    Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel.
    Wang C; Wang Y; Wang Y; Fan M; Luo F; Qian Z
    Int J Pharm; 2011 Jul; 414(1-2):251-9. PubMed ID: 21596124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fabrication and reduction-sensitive behavior of polyion complex nano-micelles based on PEG-conjugated polymer containing disulfide bonds as a potential carrier of anti-tumor paclitaxel.
    Huang H; Zhang X; Yu J; Zeng J; Chang PR; Xu H; Huang J
    Colloids Surf B Biointerfaces; 2013 Oct; 110():59-65. PubMed ID: 23711777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and evaluation of paclitaxel-loaded reactive oxygen species and glutathione redox-responsive poly(lactic-co-glycolic acid) nanoparticles for controlled release in tumor cells.
    Wang S; Han F; Xie L; Liu Y; Yang Q; Zhao D; Zhao X
    Nanomedicine (Lond); 2022 Sep; 17(22):1627-1648. PubMed ID: 36636982
    [No Abstract]   [Full Text] [Related]  

  • 37. pH and glutathion-responsive hydrogel for localized delivery of paclitaxel.
    Pérez E; Fernández A; Olmo R; Teijón JM; Blanco MD
    Colloids Surf B Biointerfaces; 2014 Apr; 116():247-56. PubMed ID: 24491841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-loaded pH-responsive polymeric micelles: Simulations and experiments of micelle formation, drug loading and drug release.
    Li Q; Yao W; Yu X; Zhang B; Dong J; Jin Y
    Colloids Surf B Biointerfaces; 2017 Oct; 158():709-716. PubMed ID: 28778054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, characterization, and formulation of poly-puerarin as a biodegradable and biosafe drug delivery platform for anti-cancer therapy.
    Yi T; Huang J; Chen X; Xiong H; Kang Y; Wu J
    Biomater Sci; 2019 Apr; 7(5):2152-2164. PubMed ID: 30896685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
    Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
    Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.